Congrats ACOR !

Discussion in 'Acorda Therapeutics' started by anonymous, Jul 28, 2017 at 4:15 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Perhaps you guys should read and follow Ron's Tweets - which are characterized by responsible and smart content - far from what we are getting from the current President.

    His latest Tweets on the need for adherence to measles vaccination to maintain adequate herd immunity are a good example.

    While I might have left this company, I still support my Acorda colleagues - great group of people.

    Not sure why there is so much hatred here at CafePharma.
     

  2. anonymous

    anonymous Guest

    Yeah, like Martin Shkreli. See how that works out.

    While Trump may want to take a breath before he tweets, at least he is not just putting on a show to play a part. If your lib leader was so concerned about measles vaccines, he should duly be concerned about who will pay for it and why there is a need all of a sudden--couldn't have anything to do with unfettered immigration from 3rd world countries could it?

    Face it, if it weren't for insurance, no one would be paying for Ampyra and we know Ron isn't giving it away.
     
  3. anonymous

    anonymous Guest


    There is no 'hatred' at OUR Company. The negative banter here is from one or two ex employees. Leadership is aware of this and from time to time will respond to the negativities with straight talk. Fortunately there are a few in our rank and file who post truthful and positive comments.
     
  4. anonymous

    anonymous Guest

    Ron will soon pledge to have a sliding scale for Ampyra - it will be priced based on the patients asset - for example 5% of the individual's or families assets. This would be fair because every patient will be treated equally. Ron knows that income inequality has doomed a portion of our society to live like feral dogs. Let's restore human dignity and help Ron set an asset based reimbursement program.
     
  5. anonymous

    anonymous Guest

    Rank& file again? Thx for posting sir. You are the only ego maniac to post here.
    Word is (and good source) that he is posting all over to draw attention to sell this hunka junk soon.
     
  6. anonymous

    anonymous Guest


    We apologize if that term offends...it was NOT meant to offend but as a sign of RESPECT for the legions in our loyal and hardworking sales force. As you must realize we use that term only sparingly; for that matter, it is commonly used within the pharma industry.
     
  7. anonymous

    anonymous Guest

    We also apologize for having...Inept, criminal management who treats the rank and file like dirt.
    It's time to...JUMP SHIP ASAP !

    Thanks
    HQ Insider
     
  8. anonymous

    anonymous Guest

     
  9. anonymous

    anonymous Guest

     
  10. anonymous

    anonymous Guest

    Not meant to offend and a sign of respect?! You are either a fool, oblivious or both.

    As far as using it sparingly, I would re-read your past propaganda as you show your contempt and disregard for those who do the work quite frequently.

    With every post you make, you highlight what is wrong at Acorda.

    Keep dreaming about $500. Hope you bought Regeneron shares as that is the only way you will see that number.
     
  11. anonymous

    anonymous Guest

    Real deal here.
     
  12. anonymous

    anonymous Guest

    Ron know Acorda shareholders come first - Ampyra help maximize profits - we need a sliding scale based price to ensure patients can access our drugs. Ron is a leader in creating a patient first environment - Ampyra price will be based on individuals assets

    http://us.milliman.com/uploadedFiles/insight/2017/ms-new-persepctives.pdf

    This Biogen 2017 report on MS shows that the average MS pays $5700 a MONTH for treatment and they are young disabled and low income. We need to do our part to help these patients.
     
  13. anonymous

    anonymous Guest

    Fake news from a fake poster.
    If you're HR - then name the person who is departing this week.

    This is a awesome company
    Stop the fake negative BS'ing

    Keep the struggle, Acordians will overcome!
     
  14. anonymous

    anonymous Guest

    So which is it? Shareholders come first or patients?

    I mean, we all know the real answer, but you seem conflicted between reality and utopia.
     
  15. anonymous

    anonymous Guest

    This is an offensive post to Leadership....the Team that works day and night to improve our ROI, reward our workforce, and satisfy our beloved patients who depend on our blockbuster drugs. You must be an ex-employee facing the regret of lost opportunities. Please go away ! !
     
  16. anonymous

    anonymous Guest

    Again, you just proved the point.